Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Dechra’s new products to drive growth

Dechra’s new products to drive growth

2nd April 2009

Dechra believes its new products will represent an excellent growth opportunity in the future, it has been reported.

The pet drugs company has signed a six million pound deal to develop a new item for the feline and canine markets ? which it believes could generate up to 20 million pounds, according to the Yorkshire Post.

Initially, the group ? which manufactures medication at its Dales factory in Skipton ? will pay a fee of 460,000 pounds under the licence agreement.

Later in the year when the transfer takes place, a further 90,000 pounds will be paid, the newspaper explained.

Further transactions will be completed to finalise a number of regulatory requirements, added the publication.

“We believe that the product, which has clinical advantages and complements our existing product range, represents an excellent future growth opportunity,” commented Dechra’s chief executive Ian Page.

Since the acquisition of VetXX in January 2008, the company’s veterinary products operate in ten countries across Europe, including the UK, Sweden, Norway, Portugal, Denmark and Spain.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.